bluebird bio Inc
(NAS:BLUE)
$
0.6078
0.0338 (5.89%)
Market Cap: 117.15 Mil
Enterprise Value: 240.30 Mil
PE Ratio: 0
PB Ratio: 0.29
GF Score: 25/100 
bluebird bio Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 19, 2021 / 05:55PM GMT
Release Date Price:
$19.05
(-4.04%)
Luca Issi
RBC Capital Markets, Research Division - Research Analyst
Great, hello, everybody, and thank you for dialing in. My name is Luca Issi. I'm a senior biotech analyst here at RBC Capital Markets. And today, it's our great privilege to have Nick Leschly, CEO of bluebird bio; and Philip Gregory, CSO of bluebird bio, for a fireside chat. Nick, Greg, thanks so much for joining us. How are you guys doing today?
Nick Leschly
bluebird bio, Inc. - President, CEO & Director
Doing great. Thanks for having us, Luca.
Philip D. Gregory
bluebird bio, Inc. - Chief Scientific Officer
Very good. Glad speaking to you.
Luca Issi
RBC Capital Markets, Research Division - Research Analyst
Absolutely, my pleasure. And thanks again.
Questions & Answers
Luca Issi
RBC Capital Markets, Research Division - Research Analyst
So maybe, Nick, let's start with a big picture question here. Obviously, you announced the corporate split
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers